Live Analyst Rating Changes 8035 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Frederico Gomes
AC
Frederico Gomes
ATB Cormark Capital Markets
Wall Street Analyst
★☆☆☆☆
#2487
on 13Foresight · ranked by our own returns
0%
Success Rate
-20.7%
Average Return
0 of 3 calls profitable · -41.2% vs benchmark
📈 Across the calls we could measure, roughly 0% of Frederico Gomes's ratings turned a profit when each position was held for 1 year — averaging -20.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

25 Buy 3 Hold 3 Sell
Frederico's Stock Coverage 20 ratings · 2026-07-10
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
TSE:HITI
High Tide
 Jun 17, 2026 BUY Strong Buy
+129.5% avg upside
8 analysts
$7.00
122.24% Upside
 ·
TSE:ACB
Aurora Cannabis
 Jun 12, 2026 BUY Hold
+950.6% avg upside
14 analysts
$6.50
70.96% Upside
 ·
TSE:DB
Decibel Cannabis Company
 May 22, 2026 BUY Strong Buy
+127.3% avg upside
4 analysts
$0.30
172.79% Upside
 ·
TSE:OGI
Organigram Global
 May 13, 2026 BUY Buy
+215.1% avg upside
11 analysts
$2.50
79.80% Upside
 ·
VFF
Village Farms International
 May 12, 2026 BUY Strong Buy
+362.0% avg upside
7 analysts
$4.25
114.64% Upside
 -24.7%
TSE:CURA
Curaleaf Holdings
 May 06, 2026 BUY Strong Buy
+5.2% avg upside
13 analysts
$15.75
14.65% Upside
 ·
SNDL
SNDL
 Apr 30, 2026 BUY Buy
+96.0% avg upside
5 analysts
$3.50
168.24% Upside
 -4.4%
TSE:VRNO
Verano Holdings
 Apr 30, 2026 BUY Strong Buy
+153.1% avg upside
8 analysts
$27.50
227.08% Upside
 ·
TLRY
Tilray
 Apr 02, 2026 HOLD Sell
+103.0% avg upside
23 analysts
$9.00
105.47% Upside
 -33.0%
TSE:WEED
Canopy Growth
 Mar 17, 2026 BUY Hold
+1213.0% avg upside
23 analysts
$1.40
2.29% Upside
 ·
TSE:CL
Cresco Labs
 Mar 06, 2026 BUY Strong Buy
+416.0% avg upside
13 analysts
$2.25
99.17% Upside
 ·
TRLV
Trulieve Cannabis
 Feb 27, 2026 BUY Strong Buy
+148.5% avg upside
15 analysts
$10.56
18.45% Upside
 ·
TSE:GTII
Green Thumb Industries
 Feb 26, 2026 BUY Strong Buy
+110.7% avg upside
15 analysts
$19.00
81.57% Upside
 ·
TSE:PLTH
Planet 13 Holdings
 Aug 14, 2025 SELL Strong Buy
+1854.4% avg upside
6 analysts
$0.35
94.45% Upside
 ·
TSE:TSND
TerrAscend Corp
 May 09, 2025 BUY Strong Buy
+391.0% avg upside
8 analysts
$1.50
72.32% Upside
 ·
TSE:JUSH
Jushi Holdings
 Jul 04, 2023 HOLD Buy
+484.8% avg upside
7 analysts
$0.80
19.33% Upside
 ·
TSE:AYR.A
Ayr Wellness
 Jul 04, 2023 BUY Strong Buy
+25247.9% avg upside
9 analysts
$3.50
2158.03% Upside
 ·
TSE:XLY
Auxly Cannabis Group
 Apr 04, 2023 HOLD Strong Buy
-12.6% avg upside
3 analysts
$0.05
72.30% Downside
 ·
TSE:ASG
Aurora Spine
 Jun 08, 2022 SELL Strong Sell
1 analyst
 — ·
KHRNF
Khiron Life Sciences
 Apr 18, 2022 BUY Strong Buy
+56331019.9% avg upside
1 analyst
$0.56
56331019.91% Upside
 ·
🔒 15 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Frederico Gomes — Frequently Asked Questions
How accurate are Frederico Gomes's stock ratings?
Based on the calls 13Foresight could measure, about 0% of Frederico's ratings were profitable over a one-year hold, with an average return of -20.7% per rating, or -41.2% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Frederico ranked on 13Foresight?
Frederico Gomes is currently ranked #2487 with a 1-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Frederico cover?
Frederico most recently has ratings on TSE:HITI, TSE:ACB, TSE:DB, TSE:OGI, VFF, TSE:CURA, SNDL, TSE:VRNO, TLRY, TSE:WEED, TSE:CL, TRLV and 8 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.